Pulmonary: Page 14

Inflammatory proteins could aid prognosis of PH patients

Study identifies four blood-based biomarkers related to pulmonary hypertension caused by left heart failure.

October 31, 2023

Pursuing a hopeful cure for PAH

An experimental drug may hold the key to treating pulmonary arterial hypertension.

October 25, 2023

FDA grants IDE approval for expanded study of PA sensor

Company to expand its PROACTIVE-HF 2 prospective, dual-arm study.

October 25, 2023

Sponsored

Pulmonary drug market forecast

Ascend Media

Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.

April 10, 2025

Florida hospital system implements new cryoablation therapy for AFib

The FDA approved the POLARx Cryoablation System therapy in August 2023.

October 13, 2023

Phase 2 study of novel drug reports successful reduction in rate of lung function decline in PPF patients

Study investigating idiopathic and progressive pulmonary fibrosis gives us unprecedented insights into the disease.

October 13, 2023

Prenatal echocardiogram may identify early PH in newborns

Study suggests that performing an echocardiogram during the third trimester of pregnancy could lead to early detection of persistent pulmonary hypertension of the newborn.

October 5, 2023

Sponsored

CDC respiratory virus guidance

Ascend Media

Review recommendations and updates to help prevent illness.

April 10, 2025

FDA accepts priority review for sotatercept to treat PAH in adults

Merck's phase 3 STELLAR study shows positive therapeutic outcomes of sotatercept, an activin signaling inhibitor.

October 5, 2023

Scientists effectively steer autonomous robot through active lung

Novel device makes it easier to find, identify and treat lung tumors that are difficult to locate and reach.

September 29, 2023

Using AI to increase detection, improve care of pulmonary embolism

Clinical studies positive outcomes of using artificial intelligence software to manage pulmonary embolism.

September 29, 2023

Sponsored

Pulmonary drug market forecast

Ascend Media

Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.

April 10, 2025

Mortality rates, health disparities remain high in PE patients

Data calls for further progress to reduce pulmonary embolism in minority populations.

September 26, 2023

Wide-ranging study looks to modify classification of pulmonary adenocarcinomas

Analysis addresses challenges in accurately assigning invasion status based on the World Health Organization’s classification of pulmonary adenocarcinomas.

September 26, 2023

Study suggests possible link between CF lung infections and quality of drinking water

September 16, 2023

Previous Page

Page 14 of 19

Next Page

Most Popular

Some COPD patients may be using the wrong inhaler

Oral bacterial therapy reduces respiratory infections in asthma patients

Automated PAH screening improves outcomes

The impact of biologic treatment for asthma in older adults

Nanoparticles carrying genetic therapies target lung cells

Cockroach and rodent exposure linked to poor lung function in urban children with asthma